Pleco Therapeutics Announces Final Close of its Series A Financing Raising €17.3m to Progress its Novel Plecoid Product in Acute Myeloid Leukaemia to Regulatory Filing in USA and EU
Investors: Accel (https://www.accel.com/) Creandum (https://www.creandum.com/) Index Ventures (https://www.indexventures.com/) P Capital Partners (https://pcapital.se/) Project A Ventures (https://www.project-a.com/) Teachers’ Venture Growth (https://www.otpp.com/en-ca/investments/our-investments/teachers-venture-growth/)
Barcelona’s Impress heads toward a $125M Series B round in its bid to digitize orthodontics
HQ: ES
Founded: 2019
Series B
Sector: Health Care
Investment Raised: USD 125M €
Valuation Remains Undisclosed
Investors: Claret Capital Partners (https://www.claret-capital.com/) LBO France (https://www.lbofrance.com/) Media Digital Ventures (http://www.mediadigitalventures.com/) Nickleby Capital (https://nicklebycapital.com/) Norgine Ventures (https://norgineventures.com/) TA Ventures (https://taventures.vc/) UNIQA Ventures (https://www.uniqaventures.com/)
Barcelona’s Impress heads toward a $125M Series B round in its bid to digitize orthodontics
HQ: ES
Founded: 2019
Series B
Sector: Health Care
Investment Raised: USD 125M €
Valuation Remains Undisclosed
Investors: Claret Capital Partners (https://www.claret-capital.com/) LBO France (https://www.lbofrance.com/) Media Digital Ventures (http://www.mediadigitalventures.com/) Nickleby Capital (https://nicklebycapital.com/) Norgine Ventures (https://norgineventures.com/) TA Ventures (https://taventures.vc/) UNIQA Ventures (https://www.uniqaventures.com/)
Idoven Raises $12.9 Million in Funding to Redefine Detection and Precision Medicine of Cardiovascular Diseases with AI
HQ: ES
Founded: 2018
Series A
Sector: Health Care
Investment Raised: USD 12.9M €
Valuation Remains Undisclosed
Investors: Brad Fluegel Diego Piacentini Iker Casillas Insight Partners (https://www.insightpartners.com/) Northzone (https://northzone.com/) Ron Vianu Sebastian Gunningham Vlad Lata Wayra
Proximie raises $80 million in series C funding to accelerate product expansion of the full-service connected surgical platform
HQ: UK
Founded: 2016
Series C
Sector: Health Care
Investment Raised: USD 80M €
Valuation Remains Undisclosed
Investors: Advent Life Sciences (https://www.adventls.com/) British Patient Capital (https://www.britishpatientcapital.co.uk/) Eight Roads Ventures (https://eightroads.com/en/) Emerson Collective (https://www.emersoncollective.com/) F-Prime Capital (https://fprimecapital.com/) Global Ventures (https://www.global.vc/) Maverick Ventures (https://www.maverickventures.com/) Minderoo Foundation (https://www.minderoo.org/) Mubadala (https://www.mubadala.com/) Questa Capital Management (https://www.questacapital.com/) SoftBank Vision Fund (https://visionfund.com/)
uMotif – the patient-first data capture and decentralized clinical trials platform – announces $25.5m of new investment from a fund managed by Athyrium Capital Management